Usefulness of Galectin-3 as a Biochemical Marker to Detect Ventricular and Supraventricular Arrhythmias in Children

Ewa Moric-Janiszewska1, Joanna Wawszczyk1, Aleksandra Morka2

  • 1Department of Biochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8B, 41-200 Sosnowiec, Poland.

PubMed

Insights

This study investigated galectin-3 (Gal-3) in pediatric cardiac arrhythmias. Researchers found no correlation between Gal-3 levels and arrhythmias, suggesting Gal-3 is not a useful biomarker for these conditions in children.

Area of Science:

  • Pediatric Cardiology
  • Biochemistry
  • Molecular Biology

Background:

  • Galectin-3 (Gal-3) is implicated in fibrotic disorders and heart failure pathogenesis.
  • The role of Gal-3 in pediatric supraventricular (SVa) and ventricular (Va) arrhythmias is largely unknown.

Purpose of the Study:

  • To explore the potential link between galectin concentration and idiopathic cardiac arrhythmias in pediatric patients.
  • To determine if Gal-3 can serve as a biomarker for pediatric arrhythmias.

Main Methods:

  • Prospective study involving 30 children (11-18 years) with arrhythmias and 20 controls.
  • Serum Gal-3 levels measured using enzyme-linked immunosorbent assay (ELISA).
  • Cardiac arrhythmia diagnosis confirmed via 24-hour Holter ECG recording.

Main Results:

  • A significant association was observed between creatinine kinase (CK) and Gal-3 in patients with SVa arrhythmias.
  • No statistically significant correlation was found between Gal-3 concentration and the occurrence of cardiac arrhythmias studied.
  • This suggests CK may influence Gal-3 levels in SVa patients.

Conclusions:

  • Galectin-3 does not appear to be a reliable biomarker for diagnosing idiopathic cardiac arrhythmias in pediatric patients.
  • Further research may be needed to understand the relationship between CK and Gal-3 in pediatric SVa arrhythmias.